PCRX

Pacira BioSciences Inc.

Price

$25.02

return (12m)

0.72%

p/e

67.45

p/bv

1.47

DIVIDEND YIELD

0.00%

PCRX price

Pacira BioSciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PCRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.51%

3 months

-1.94%

1 year

0.72%

2 years

57.46%

5 years

-49.40%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PCRX

Valuation

P/E

67.45

Sector -3.46

Industry -3.46

P/BV

1.47

Sector 1.94

Industry 1.94

P/Revenue (PSR)

1.32

Sector 1.96

Industry 1.96

EV/EBITDA

40.79

Sector -216.42

Industry -216.42

EV/EBIT

194.38

Sector -46.11

Industry -46.11

P/EBITDA

8.50

Sector -21.02

Industry -21.02

P/EBIT

31.90

Sector -27.60

Industry -27.60

P/Total Assets

0.79

Sector 1.14

Industry 1.14

P/Net Current Assets

22.85

Sector -10.24

Industry -10.24

P/Working Capital

2.00

Sector -162.19

Industry -162.19

EPS

0.37

Sector -1.78

Industry -1.78

BVPS

17.03

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

79.21%

Sector 41.35%

Industry 41.35%

EBITDA Margin

14.01%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

2.94%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

2.66%

Sector -35.47%

Industry -35.47%

Net Profit Margins

1.96%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.15

Sector 0.03

Industry 0.03

Profitability

ROE

2.18%

Sector -57.40%

Industry -57.40%

ROA

1.18%

Sector -59.43%

Industry -59.43%

ROIC

5.22%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.04

Sector 2.91

Industry 2.91

Net Debt / EBITDA

4.16

Sector -21.98

Industry -21.98

Net Debt / EBIT

19.82

Sector -8.44

Industry -8.44

Net Debt / Equity

0.17

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

0.54

Sector -0.85

Industry -0.85

Equity/Assets

0.54

Sector 0.46

Industry 0.46

Liabilities/Assets

0.46

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

6.62%

Sector -

Industry -

5Y Earnings CAGR

-19.00%

Sector -

Industry -

Fundamentals PCRX

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Pacira BioSciences ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$25.02

Fair Value

$11.91

Upside

-52.41%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PCRX Pacira BioSciences Inc.	$25.02	-0.99%	0.00%	67.45	1.47	2.18%	1.96%
PFE Pfizer Inc.	$27.48	8.11%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.59%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PCRX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Pacira BioSciences

Pacira BioSciences Inc.

Average Investor10 user rating

4.0 (2 people)

United States

20 years

Founded: 2006

2011

Time since IPO - 15 years

624

Employees

Pacira BioSciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $987.34 million, with shareholders equity totaling $671.98 million.

The company employs approximately 624 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Pacira BioSciences Inc. reported $746.16 million in revenue, generating net income of $14.64 million.

Key financial metrics include a P/E ratio of 67.45, a price-to-book (P/B) ratio of 1.47, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PCRX.

Market cap

$987.34 million

Net worth

$671.98 million

$671,976,000.00

Assets

$1.24 billion

$1,243,978,000.00

Total Shares Outstanding

39.46 million

39,462,000

Average Daily Trading Volume

$598.44 Thousand

$598,440.00

Sector

Health Care

Industry

Biotechnology

PCRX

PCRX revenue and profits

Financial Results PCRX

DRAG THE FRAME TO SEE MORE DATA

PCRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 20,83% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$226.17 47,96% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$259.97 14,69% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$143.18 65,85% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$156.59 --6,84% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$27.48 7,47% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 20,83% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$226.17 47,96% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$259.97 14,69% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$143.18 65,85% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$156.59 --6,84% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$27.48 7,47% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of Pacira BioSciences (PCRX) today?

The current price of Pacira BioSciences (PCRX) is $25.02. The stock began the year trading around $25.88 and is currently priced at $25.02. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Pacira BioSciences (PCRX) pay dividends?

Pacira BioSciences (PCRX) did not pay dividends over the past year.

Is Pacira BioSciences (PCRX) a good investment?

Pacira BioSciences (PCRX) is currently trading at $25.02 with a P/E ratio of 67.45. This represents a 7,304% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.72%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Pacira BioSciences (PCRX) stock?

You can buy Pacira BioSciences (PCRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PCRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Pacira BioSciences (PCRX) yield today?

Over the past month, Pacira BioSciences (PCRX) has returned -5.51% — 0.72% over the past year, and -49.40% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Pacira BioSciences (PCRX) today at the current price of $25.02 your total investment would be $2,502.00.

Based on historical performance, the investment would have grown to approximately:

$2,520.01 after 1 year
$1,266.01 after 5 years
$2,502.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PCRX

Pacira BioSciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PCRX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING PCRX WITH OTHER STOCK

ABOUT Pacira BioSciences

Pacira BioSciences Inc.

United States

20 years

2011

624

PROFIT X PRICE PCRX

Financial Results PCRX

PCRX cash flow

Asset, Revenue and Profit Growth - PCRX

PCRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions